Fertility Preservation in the Adolescent and Young Adult Population

OSUWexnerbloglogo2014 Fertility Preservation in the Adolescent and Young Adult Population will be discussed on this CME webcast. We are going to show you just how far medical science has come in order to preserve fertility in girls and young women. Joining our moderator in the studio is Associate Professor of Obstetrics and Gynecology, Dr. Leslie Appiah.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: EXPLAIN the effects of cancer treatments on fertility and limits of risk stratification; DISCUSS standard and novel fertility preservation therapies for patients with cancer; and DESCRIBE reproductive late effects and management options in survivorship.

You’ll also learn about the following:

  • Common indications for fertility preservation
  • Fertility preservation options
  • How long can tissues safely be frozen
  • How many eggs should be frozen
  • Options for pre-pubescent girls
  • Options for women undergoing oophorectomy
  • Fertility preservation for men

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Update on Adult Congenital Heart Disease

OSUWexnerbloglogo2014 Update on Adult Congenital Heart Disease. On this CME webcast, we’re going to update you on some of the unique challenges of diagnosing and treating adults with congenital heart disease. Joining our moderator in the studio is cardiologist and Assistant Professor of Internal Medicine, Dr. Saurabh Rajpal.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: INCREASE awareness about increasing prevalence of Adult Congenital Heart disease; and DISCUSS common congenital
heart disease diagnoses encountered in adult practice.

You’ll also learn about the following:

  • Common causes of congenital heart disease in adult patients
  • Changing prevalence of congenital heart disease in adults
  • Follow up testing and monitoring
  • Marfan syndrome

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Learn About New Developments in Asthma on CME Webcast

OSUWexnerbloglogo2014 Learn About New Developments in Asthma on CME Webcast. Today on MedNet, we’re going to tell you about the newest developments in asthma management to help you choose the right medications for your patients. Joining our moderator in the studio to update us on asthma management in adults is pulmonologist and Associate Professor of Internal Medicine, Dr. Jennifer McCallister. And then to update us on asthma management in children is pulmonologist and Associate Professor of Pediatrics, Dr. Elizabeth Allen.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DISCUSS important safety considerations in the use of long-acting beta-agonists in asthma care; SELECT the most appropriate initial inhaler therapy for a patient with asthma-COPD overlap; IDENTIFY new treatment options for both acute and chronic asthma management; and RECOGNIZE protracted bacterial bronchitis – an asthma mimic in young children.

You’ll also learn about the following:

  • Pathogenesis of asthma
  • Diagnosing asthma in children
  • Equivalency of different brands of inhaled corticosteroids and long-acting beta agonists
  • Asthma medications and pregnancy
  • Allergy testing and desensitization
  • School-based asthma treatment program
  • Exhaled nitric oxide
  • Leukotriene inhibitors in adult asthma
  • Bronchial thermoplasty
  • Peak flow monitoring
  • Role of increasing the dose of inhaled steroids in asthma exacerbations

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.